痰热清注射液用于重症脑出血患者肺部感染及细胞因子的临床观察

Clinical Observation of Tanreqing Injection in the Treatment of Pulmonary Infection and Cytokines in Patients with Severe Cerebral Hemorrhage

目的:研究痰热清注射液在重症脑出血并发肺部感染中的应用价值。方法:利用随机数表法均分100例重症脑出血并发肺部感染患者,实验和对照两组都接受常规治疗,实验组加用痰热清注射液,比较两组的炎性指标和疗效。结果:实验组治疗后的炎性指标优于对照组,P<0.05。实验组总有效率94.0%比对照组78.0%高,P<0.05。结论:在重症脑出血并发肺部感染中应用痰热清注射液,能抑制炎性反应进展,提高疗效。

Objective:To study the application value of Tanreqing injection in severe cerebral hemorrhage and pulmonary infection.Methods:100 patients with severe cerebral hemorrhage and pulmonary infection were divided by random number table method.Both the experimental group and the control group received routine treatment,and the experimental group received Tanreqing injection.The inflammatory indicators and curative effects were compared between the two groups.Results:The inflammatory index of the experimental group after treatment was better than that of the control group,P<0.05.The total effective rate of the experimental group was 94.0%,higher than the control group with 78.0%,P<0.05.Conclusion:The application of Tanreqing injection in severe cerebral hemorrhage and pulmonary infection can inhibit the progress of inflammatory reaction and improve the curative effect.